HARMONY BIOSCIENCES HLDGS IN's ticker is HRMY and the CUSIP is 413197104. A total of 183 filers reported holding HARMONY BIOSCIENCES HLDGS IN in Q2 2022. The put-call ratio across all filers is 0.10 and the average weighting 1.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $16,653,648 | -6.7% | 508,198 | +0.2% | 0.01% | 0.0% |
| Q2 2023 | $17,853,083 | +33.1% | 507,334 | +23.5% | 0.01% | +20.0% |
| Q1 2023 | $13,417,093 | -28.4% | 410,937 | +20.8% | 0.01% | -28.6% |
| Q4 2022 | $18,739,675 | +1.8% | 340,103 | -18.1% | 0.01% | 0.0% |
| Q3 2022 | $18,400,000 | -2.5% | 415,451 | +7.4% | 0.01% | 0.0% |
| Q2 2022 | $18,870,000 | -0.5% | 386,912 | -0.7% | 0.01% | +16.7% |
| Q1 2022 | $18,962,000 | -20.6% | 389,760 | -30.4% | 0.01% | -14.3% |
| Q4 2021 | $23,873,000 | -6.7% | 559,868 | -16.2% | 0.01% | 0.0% |
| Q3 2021 | $25,596,000 | +34.0% | 667,784 | -1.3% | 0.01% | +16.7% |
| Q2 2021 | $19,101,000 | -4.4% | 676,620 | +11.9% | 0.01% | 0.0% |
| Q1 2021 | $19,985,000 | +7.6% | 604,865 | +17.8% | 0.01% | 0.0% |
| Q4 2020 | $18,566,000 | +66.1% | 513,570 | +55.8% | 0.01% | +50.0% |
| Q3 2020 | $11,176,000 | – | 329,668 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Valor Management LLC | 11,218,033 | $367,614,941 | 98.94% |
| Nan Fung Group Holdings Ltd | 368,665 | $12,081,152 | 9.78% |
| venBio Partners LLC | 1,035,396 | $33,929,927 | 9.62% |
| Vivo Capital, LLC | 2,606,247 | $85,406,714 | 9.36% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 314,500 | $10,306,165 | 3.47% |
| AlphaCentric Advisors LLC | 122,000 | $3,997,940 | 2.27% |
| ASHFORD CAPITAL MANAGEMENT INC | 434,148 | $14,227,030 | 2.09% |
| Altium Capital Management LP | 117,000 | $3,834,090 | 2.00% |
| NEUMEIER POMA INVESTMENT COUNSEL LLC | 595,490 | $19,514,207 | 1.90% |
| TANG CAPITAL MANAGEMENT LLC | 271,200 | $8,887,224 | 1.25% |